Welcome to Daval International
Daval International is a small but expanding pharmaceutical development company which aims to become a leader in its field. Research has focused on the application of caprine hyperimmune serum derivatives to a range of human and veterinary disorders. Following the successful negotiation of substantial research contracts Daval has now launched a broad R&D program, which covers basic laboratory research and randomised clinical trials.
Daval is "Working With Nature" to develop safe palliative treatments for chronic human and veterinary inflammatory diseases.
Latest News
18/04/08 - Clinical Trial Authorisation
We are pleased to inform shareholders that a Clinical Trial Authorisation has been obtained from the... Read
20/03/08 - Multiple Sclerosis Trial
Recruitment for the Aimspro Trial for bladder function in Multiple Sclerosis is now oversubscribed. ... Read